Two industry-sponsored studies investiaged needs of people with pulmonary hypertesion and interstitial lung disease.

Columnist Anna Jeter was recently reminded that she's still absorbing lessons from her chronic illness after 25 years of ...

Winrevair was approved to treat pulmonary arterial hypertension (PAH), a progressive disorder caused by a constriction of ...

Pulmonary hypertension (PH), a serious lung and heart condition, elevates blood pressure in lung arteries, causing shortness ...

The advice to " go with your gut " is ubiquitous but not always on point. For instance, your gut may tell you not to apply ...

When a person’s asthma is severe or isn’t managed well by typical protocols, they may be a good candidate for pulmonary ...

New data suggests clinicians may be slower to recognize sepsis in people with pulmonary arterial hypertension.

Insmed sees growth with ARIKAYCE and upcoming Brensocatib approval. Find out why INSM stock is a strong pick with significant ...

News on Inhibikase's promising treatments for PAH and Parkinson's Disease, supported by FDA approval and substantial funding.

Positive results from a study of Winrevair could help the drugmaker achieve sales growth past top-seller Keytruda’s upcoming ...